|

Transcranial Direct Current Stimulation for the Treatment of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors

RECRUITINGN/ASponsored by University of Michigan Rogel Cancer Center
Actively Recruiting
PhaseN/A
SponsorUniversity of Michigan Rogel Cancer Center
Started2026-09-10
Est. completion2028-02
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
Locations1 site

Summary

This clinical trial tests how well a type of non-invasive brain stimulation called transcranial direct current stimulation (tDCS) works to treat chemotherapy induced peripheral neuropathy (CIPN) in cancer survivors. CIPN is numbness, tingling, pain, and movement problems that can develop after chemotherapy as a result of changes to the nerves. A non-invasive form of brain stimulation called tDCS, applied to the area of the brain involved in sensation and movement, can temporarily improve the ability to detect vibration and temperature, as well as balance and walking, which may improve sensation and reduce pain in cancer survivors with CIPN.

Eligibility

Age: 18 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria:

* 18 to 85 years of age
* Diagnosis of cancer, stages I-IV
* Cancer survivor (not currently receiving chemotherapy, radiation, or immunotherapy)
* Presence of CIPN defined as new, length-dependent numbness, tingling, and/or pain that developed with neurotoxic chemotherapy
* CIPN20 score ≥ 20
* Able to walk unassisted
* Proficient in English

Exclusion Criteria:

* Known brain metastases
* Known neurological conditions aside from chemotherapy-induced peripheral neuropathy (CIPN)
* History of brain or spinal surgery
* Neuropathy other than CIPN
* Significant hearing or vision deficits
* Vestibulopathy
* Currently receiving chemotherapy, radiation therapy, or immunotherapy
* Contraindications to transcranial direct current stimulation (tDCS), including recent seizures
* Presence of metallic objects in the head
* Presence of specific implanted medical devices (e.g., deep brain stimulator, cochlear implant, vagus nerve stimulator, spinal cord stimulator, pacemakers, and intracardiac devices)
* Active scalp dermatological conditions

Conditions4

CancerChemotherapy-induced Peripheral NeuropathyHematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Locations1 site

University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109
Eshaka Eshwar734-232-5901eshaka@med.umich.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.